128 related articles for article (PubMed ID: 6542016)
1. Influence of concomitant infusion of thymidine and inosine on methotrexate activity in normal and P388-bearing mice.
Uitendaal MP; Schornagel JH; Leyva A; Pinedo HM
Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1527-32. PubMed ID: 6542016
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine.
Semon JH; Grindey GB
Cancer Res; 1978 Sep; 38(9):2905-11. PubMed ID: 679199
[No Abstract] [Full Text] [Related]
3. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
[TBL] [Abstract][Full Text] [Related]
4. Modulation versus rescue of antimetabolite toxicity by salvage metabolites administered by continuous infusion.
Grindey GB; Semon JH; Pavelic ZP
Antibiot Chemother (1971); 1978; 23():295-304. PubMed ID: 306219
[TBL] [Abstract][Full Text] [Related]
5. Synergism between purines and thymidine (TDR) in reversal of methotrexate (MTX) toxicity in mice using continuous infusions.
Uitendaal MP; Schornagel JH; Leyva A; Pinedo HM
Adv Exp Med Biol; 1984; 165 Pt B():401-5. PubMed ID: 6720437
[No Abstract] [Full Text] [Related]
6. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
8. Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).
Grossie VB; Valdivieso M; Drewinko B; Loo TL
Cancer Chemother Pharmacol; 1984; 13(1):27-30. PubMed ID: 6539657
[TBL] [Abstract][Full Text] [Related]
9. In vivo antitumor activity of the bitter melon (Momordica charantia).
Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ
Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
Lin TS; Fischer PH; Prusoff WH
Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
[No Abstract] [Full Text] [Related]
11. Effects of allopurinol on the therapeutic efficacy of methotrexate.
Grindey GB; Moran RG
Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828
[TBL] [Abstract][Full Text] [Related]
12. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
Warzocha K; Robak T
Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidines.
Harrap KR; Taylor GA; Browman GP
Chem Biol Interact; 1977 Jul; 18(1):119-28. PubMed ID: 302148
[TBL] [Abstract][Full Text] [Related]
14. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
Machida S; Ito Y; Hoshino A
Gan To Kagaku Ryoho; 1985 Feb; 12(2):298-302. PubMed ID: 3918506
[TBL] [Abstract][Full Text] [Related]
15. [Antitumor effect of methylene blue in vivo].
Lai BT
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):98-100. PubMed ID: 2806052
[TBL] [Abstract][Full Text] [Related]
16. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
Samuels LL; Straw JA
Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
[TBL] [Abstract][Full Text] [Related]
17. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
Wampler GL; Carter WH; Campbell ED
Cancer Invest; 1987; 5(6):523-33. PubMed ID: 3442730
[TBL] [Abstract][Full Text] [Related]
18. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
Marañda E; Szmigielska A; Robak T
Cancer Invest; 1999; 17(2):95-101. PubMed ID: 10071592
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
20. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]